Concentration of matrix metalloproteinase-9 in the jugular bulb during carotid endarterectomy correlates with severity of intraoperative cerebral ischemia

Cerebrovascular Diseases

Volumn 25, Issue 6, 2008, Pages 587-592

  Ishigaki, Daiya ^a   Ogasawara, Kuniaki ^a   Suga, Yasunori ^a   Saito, Hideo ^a   Chida, Kohei ^a   Kobayashi, Masakazu ^a   Yoshida, Kenji ^a   Otawara, Yasunari ^a   Ogawa, Akira ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Carotid endarterectomy; Cerebral ischemia; Matrix metalloproteinase 9

Indexed keywords

GELATINASE B;

ADULT; AGED; ARTERY CLAMP; ARTICLE; BRAIN ISCHEMIA; BRAIN OXYGEN CONSUMPTION; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); FEMALE; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; INTRAOPERATIVE PERIOD; INTRAVENOUS CATHETER; JUGULAR VEIN; MALE; NEAR INFRARED SPECTROSCOPY; NEUROLOGIC EXAMINATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; CAROTID ARTERY, INTERNAL; CAROTID STENOSIS; ENDARTERECTOMY, CAROTID; FEMALE; HUMANS; INTRAOPERATIVE COMPLICATIONS; ISCHEMIC ATTACK, TRANSIENT; JUGULAR VEINS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; OXYGEN; SPECTROSCOPY, NEAR-INFRARED;

EID: 45549083220     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000134375     Document Type: Article

References (24)

1. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990;6:121-125.
2. Mun-Bryce S, Rosenberg GA: Matrix metalloproteinases in cerebrovascular disease. J Cereb Blood Flow Metab 1998;18:1163-1172.
3. Heo JH, Lucero J, Abumiya T, Koziol JA, Copeland BR, del Zoppo GJ: Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J Cereb Blood Flow Metab 1999;19:624-633.
4. Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC: Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 1998;29:1020-1030.
5. Montaner J, Alvarez-Sabín J, Molina C, Anglés A, Abilleira S, Arenillas J, González MA, Monasterio J: Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke 2001;32:1759-1766.
6. Fatar M, Stroick M, Griebe M, Hennerici M: Matrix metalloproteinases in cerebrovascular diseases. Cerebrovasc Dis 2005;20:141-151.
7. Montaner J, Rovira A, Molina CA, Arenillas JF, Ribó M, Chacón P, Monasterio J, Alvarez-Sabín J: Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke. J Cereb Blood Flow Metab 2003;23:1403-1407.
8. Rosell A, Ortega-Aznar A, Alvarez-Sabín J, Fernández- Cadenas I, Ribó M, Molina CA, Lo EH, Montaner J: Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke 2006;37:1399-1406.
9. Suehiro E, Fujisawa H, Akimura T, Ishihara H, Kajiwara K, Kato S, Fujii M, Yamashita S, Maekawa T, Suzuki M: Increased matrix metalloproteinase-9 in blood in association with activation of interleukin-6 after traumatic brain injury: influence of hypothermic therapy. J Neurotrauma 2004;21:1706-1711.
10. Moore WS, Barnett HJ, Beebe HG, Bernstein EF, Brener BJ, Brott T, Caplan LR, Day A, Goldstone J, Hobson RW 2nd: Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the ad hoc Committee, American Heart Association. Stroke 1995;26:188-201.
11. Mille T, Tachimiri ME, Klersy C, Ticozzelli G, Bellinzona G, Blangetti I, Pirrelli S, Lovotti M, Odero A: Near infrared spectroscopy monitoring during carotid endarterectomy: which threshold value is critical? Eur J Vasc Endovasc Surg 2004;27:646-650.
12. North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-453.
13. Fujimoto N, Hosokawa N, Iwata K, Shinya T, Okada Y, Hayakawa T: A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase, gelatinase B) using monoclonal antibodies. Clin Chim Acta 1994;231:79-88.
14. Nara I, Shiogai T, Hara M, Saito I: Comparative effects of hypothermia, barbiturate, and osmotherapy for cerebral oxygen metabolism, intracranial pressure, and cerebral perfusion pressure in patients with severe head injury. Acta Neurochir 1998;71:22-26.
15. Gondalia J, Fagerberg B, Hulthe J, Karlström L, Nilsson U, Waters S, Jonsson O: Relationships between free radical levels during carotid endarterectomy and markers of arteriosclerotic disease. Int J Med Sci 2007;4:124-130.
16. Astrup J, Siesjo BK, Symon L: Thresholds in cerebral ischemia: the ischemic penumbra. Stroke 1981;12:723-725.
17. Komoribayashi N, Ogasawara K, Kobayashi M, Saitoh H, Terasaki K, Inoue T, Ogawa A: Cerebral hyperperfusion after carotid endarterectomy is associated with preoperative hemodynamic impairment and intraoperative cerebral ischemia. J Cereb Blood Flow Metab 2006;26:878-884.
18. Saito H, Ogasawara K, Komoribayashi N, Kobayashi M, Inoue T, Otawara Y, Ogawa A: Concentration of malondialdehyde-modified low-density lipoprotein in the jugular bulb during carotid endarterectomy correlates with development of postoperative cognitive impairment. Neurosurgery 2007;60:1067-1074.
19. Sahlein DH, Heyer EJ, Rampersad A, Winfree CJ, Solomon RA, Benvenisty AI, Quest DO, Du E, Connolly ES: Failure of intraoperative jugular bulb S-100B and neuron-specific enolase sampling to predict cognitive injury after carotid endarterectomy. Neurosurgery 2003;53:1243-1250.
20. van der Zwan A, Hillen B, Tulleken CA, Dujovny M, Dragovic L: Variability of the territories of the major cerebral arteries. J Neurosurg 1992;77:927-940.
21. Zhao B, Ikeda Y, Ihara H, Urano T, Fan WY, Mikawa S, Suzuki Y, Kondo K, Sato K, Nagai N, Umemura K: Essential role of endogenous tissue plasminogen activator through matrix metalloproteinase 9 induction and expression on heparin-produced cerebral hemorrhage after cerebral ischemia in mice. Blood 2004;103:2610-2616.
22. Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K, Hayakawa T: Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells: purification and activation of the precursor and enzymic properties. J Biol Chem 1992;267:21712-21719.
23. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI: SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 1989;264:17213-17221.
24. Hanemaaijer R, Visser H, Konttinen YT, Koolwijk P, Verheijen JH: A novel and simple immunocapture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: saliva from patients with Sjögren's syndrome contain increased latent and active gelatinase-B levels. Matrix Biol 1998;17:657-665.